Diagnostic performance of a dedicated 1.5-T breast MR imaging system

Radiology

Volumn 265, Issue 1, 2012, Pages 51-58

  Hillman, Bruce J ^a,b   Harms, Steven E ^c   Stevens, Gary ^d   Stough, Rebecca G ^e   Hollingsworth, Alan B ^e   Kozlowski, Kamilia F ^f   Moss, Lawrence J ^g  

^a ACR Image Metrix   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c Breast Center of Northwest Arkansas   (United States)

^d Dynastat Consulting   (United States)

^e Mercy Women's Center   (United States)

^f Knoxville Compreh Breast Center   (United States)

^g UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BREAST BIOPSY; BREAST CANCER; CANCER SCREENING; COHORT ANALYSIS; COMPUTER ASSISTED DIAGNOSIS; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIGITAL MAMMOGRAPHY; FALSE POSITIVE RESULT; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; BREAST NEOPLASMS; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 84866622811     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.12110600     Document Type: Article

References (29)

1. Bluemke DA, Gatsonis CA, Chen MH, et al. Magnetic resonance imaging of the breast prior to biopsy. JAMA 2004;292(22):2735-2742. (Pubitemid 39628252)
2. Schnall MD, Blume J, Bluemke DA, et al. Diagnostic architectural and dynamic features at breast MR imaging: multicenter study. Radiology 2006;238(1):42-53. (Pubitemid 43010579)
3. Kuhl CK, Schmutzler RK, Leutner CC, et al. Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: preliminary results. Radiology 2000;215(1):267-279. (Pubitemid 30190541)
4. Kuhl CK, Weigel S, Schrading S, et al. Prospective multicenter cohort study to refine management recommendations for women at elevated familial risk of breast cancer: the EVA trial. J Clin Oncol 2010;28(9):1450-1457.
5. Rijnsburger AJ, Obdeijn IM, Kaas R, et al. BRCA1-associated breast cancers present differently from BRCA2-associated and familial cases: long-term follow-up of the Dutch MRISC Screening Study. J Clin Oncol 2010;28(36):5265- 5273.
6. Warner E, Plewes DB, Hill KA, et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 2004;292(11):1317-1325. (Pubitemid 39223222)
7. Leach MO, Boggis CR, Dixon AK, et al. Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). Lancet 2005;365(9473):1769-1778. (Pubitemid 40744657)
8. Lehman CD, Isaacs C, Schnall MD, et al. Cancer yield of mammography, MR, and US in high-risk women: prospective multi-institution breast cancer screening study. Radiology 2007;244(2):381-388. (Pubitemid 47080869)
9. Lehman CD, Blume JD, Weatherall P, et al. Screening women at high risk for breast cancer with mammography and magnetic resonance imaging. Cancer 2005;103(9):1898-1905. (Pubitemid 40563263)
10. Sardanelli F, Podo F, D'Agnolo G, et al. Multicenter comparative multimodality surveillance of women at genetic-familial high risk for breast cancer (HIBCRIT study): interim results. Radiology 2007;242(3):698-715.
11. Soderstrom CE, Harms SE, Copit DS, et al. Three-dimensional RODEO breast MR imaging of lesions containing ductal carcinoma in situ. Radiology 1996;201(2):427-432. (Pubitemid 26357638)
12. Orel SG, Mendonca MH, Reynolds C, Schnall MD, Solin LJ, Sullivan DC. MR imaging of ductal carcinoma in situ. Radiology 1997;202(2):413-420. (Pubitemid 27051736)
13. Menell JH, Morris EA, Dershaw DD, Abramson AF, Brogi E, Liberman L. Determination of the presence and extent of pure ductal carcinoma in situ by mammography and magnetic resonance imaging. Breast J 2005;11(6):382-390. (Pubitemid 41743410)
14. Kuhl CK, Mielcareck P, Klaschik S, et al. Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions? Radiology 1999;211(1):101-110. (Pubitemid 29161739)
15. Rodenko GN, Harms SE, Pruneda JM, et al. MR imaging in the management before surgery of lobular carcinoma of the breast: correlation with pathology. AJR Am J Roentgenol 1996;167(6):1415-1419. (Pubitemid 26418723)
16. Weinstein SP, Orel SG, Heller R, et al. MR imaging of the breast in patients with invasive lobular carcinoma. AJR Am J Roentgenol 2001;176(2):399-406. (Pubitemid 32105648)
17. Harms SE. The use of breast magnetic resonance imaging in ductal carcinoma in situ. Breast J 2005;11(6):379-381. (Pubitemid 41743409)
18. Wedegärtner U, Bick U, Wörtler K, Rummeny E, Bongartz G. Differentiation between benign and malignant findings on MR-mammography: usefulness of morphological criteria. Eur Radiol 2001;11(9):1645-1650. (Pubitemid 32821373)
19. Liberman L, Morris EA, Lee MJ, et al. Breast lesions detected on MR imaging: features and positive predictive value. AJR Am J Roentgenol 2002;179(1):171-178. (Pubitemid 34694831)
20. Gutierrez RL, DeMartini WB, Eby PR, Kurland BF, Peacock S, Lehman CD. BI-RADS lesion characteristics predict likelihood of malignancy in breast MRI for masses but not for nonmasslike enhancement. AJR Am J Roentgenol 2009;193(4):994-1000.
21. Baltzer PA, Benndorf M, Dietzel M, Gajda M, Runnebaum IB, Kaiser WA. False-positive findings at contrast-enhanced breast MRI: a BI-RADS descriptor study. AJR Am J Roentgenol 2010;194(6):1658-1663.
22. Teifke A, Hlawatsch A, Beier T, et al. Undetected malignancies of the breast: dynamic contrast-enhanced MR imaging at 1.0 T. Radiology 2002;224(3):881-888. (Pubitemid 34919827)
23. Fischer U, Kopka L, Grabbe E. Breast carcinoma: effect of preoperative contrast-enhanced MR imaging on the therapeutic approach. Radiology 1999;213(3):881-888.
24. Hollingsworth AB, Stough RG, O'Dell CA, Brekke CE. Breast magnetic resonance imaging for preoperative locoregional staging. Am J Surg 2008;196(3):389-397.
25. Harms SE, Harms SS. Making quality technical decisions: No free lunch in MRI. Semin Breast Dis 2008;11(2):51-66.
26. Block KT, Frahm J. Spiral imaging: a critical appraisal. J Magn Reson Imaging 2005;21(6):657-668. (Pubitemid 40770856)
27. Meyer CH, Hu BS, Nishimura DG, Macovski A. Fast spiral coronary artery imaging. Magn Reson Med 1992;28(2):202-213. (Pubitemid 23027662)
28. Harms SE, Flamig DP, Hesley KL, et al. MR imaging of the breast with rotating delivery of excitation off resonance: clinical experience with pathologic correlation. Radiology 1993;187(2):493-501. (Pubitemid 23127861)
29. Schnall MD, Blume J, Bluemke DA, et al. MRI detection of distinct incidental cancer in women with primary breast cancer studied in IBMC 6883. J Surg Oncol 2005;92(1):32-38. (Pubitemid 41416426)